Literature DB >> 10750881

Update on colorectal cancer.

D R Rudy1, M J Zdon.   

Abstract

An estimated 129,400 new cases of colorectal cancer occurred in the United States during 1999. The lifetime risk of developing this cancer is 2.5 to 5 percent in the general population but two to three times higher in persons who have a first-degree relative with colon cancer or an adenomatous polyp. Between 70 and 90 percent of colorectal cancers arise from adenomatous polyps, whereas only 10 to 30 percent arise from sessile adenomas. Tumors or polyps that develop proximal to the splenic flexure carry a poorer prognosis than those that arise more distally, in part because of delayed diagnosis secondary to later development of symptoms. The Dukes system is the classic staging method for colorectal cancer; the TNM staging system is more detailed and therefore more useful for surgical purposes. Although screening guidelines vary, most agree that colorectal cancer screening should begin at 50 years of age in patients without a personal or family history of colorectal cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10750881

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  16 in total

1.  Negative colorectal polyp biopsies: the utility of cutting deeper levels.

Authors:  Brian A Schick; Carolyn A McLean; David K Driman
Journal:  Virchows Arch       Date:  2015-10-16       Impact factor: 4.064

2.  Racial differences in the anatomical distribution of colorectal cancer: a study of differences between American and Chinese patients.

Authors:  San-Hua Qing; Kai-Yun Rao; Hui-Yong Jiang; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions.

Authors:  Olena Mandrik; Chloe Thomas; Sophie Whyte; James Chilcott
Journal:  Pharmacoeconomics       Date:  2022-01-07       Impact factor: 4.558

4.  Detection of colorectal cancer in symptomatic outpatients without visible rectal bleeding: Validity of the fecal occult blood test.

Authors:  Niels Christian Bjerregaard; Anders Tøttrup; Henrik Toft Sørensen; Søren Laurberg
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

5.  Colorectal cancer: prognostic values.

Authors:  Suzana Manxhuka-Kerliu; Skender Telaku; Halil Ahmetaj; Arijeta Baruti; Sadushe Loxha; Agron Kerliu
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

6.  Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.

Authors:  Mechteld C de Jong; Skye C Mayo; Carlo Pulitano; Serena Lanella; Dario Ribero; Jennifer Strub; Catherine Hubert; Jean-François Gigot; Richard D Schulick; Michael A Choti; Luca Aldrighetti; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2009-10-01       Impact factor: 3.452

7.  The association of serum lipids with the histological pattern of rectosigmoid adenoma in Taiwanese adults.

Authors:  Zih-Jie Sun; Ying-Hsiang Huang; Jin-Shang Wu; Yi-Ching Yang; Ying-Fang Chang; Feng-Hwa Lu; Chih-Jen Chang
Journal:  BMC Gastroenterol       Date:  2011-05-15       Impact factor: 3.067

8.  Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.

Authors:  Grace Hui-Min Wu; Yi-Ming Wang; Amy Ming-Fang Yen; Jau-Min Wong; Hsin-Chih Lai; Jane Warwick; Tony Hsiu-Hsi Chen
Journal:  BMC Cancer       Date:  2006-05-24       Impact factor: 4.430

9.  Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study.

Authors:  S Bhattacharjya; R Aggarwal; B R Davidson
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

10.  Design considerations in a sib-pair study of linkage for susceptibility loci in cancer.

Authors:  Richard A Kerber; Christopher I Amos; Beow Y Yeap; Dianne M Finkelstein; Duncan C Thomas
Journal:  BMC Med Genet       Date:  2008-07-10       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.